目前,肝癌是肝移植的适应证之一。根治性肝部分切除的5年生存率仍然在30%左右徘徊,而肝癌肝移植的5年生存率已达到50%左右。虽然肝癌患者肝移植术后早期效果良好,但肿瘤复发和转移导致的远期低存活率严重制约了肝癌肝移植的开展。现就国内外肝癌肝移植术后肝癌复发的原因和防治 Currently, liver cancer is one of the indications for liver transplantation. The 5-year survival rate of radical hepatectomy is still hovering around 30%, while the 5-year survival rate of liver cancer liver transplantation has reached about 50%. Although the effect of early liver transplantation in patients with liver cancer is good, long-term low survival rate due to tumor recurrence and metastasis severely restricts the development of liver cancer liver transplantation. Recurrence of hepatocellular carcinoma after liver transplantation at home and abroad and prevention and treatment